Stock Taper

Pricing Sign Up Log In

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF • Roundhill Investments

$31.98 ▼ -0.25% (-0.08)

Managing Company Roundhill Investments

Asset Under Management $53.30M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $37.15

52w Low $22.36

Volume 11,824

Avg Volume 28,161

Asset Class Equity

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.

Managing Company Roundhill Investments

Asset Under Management $53.30M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $37.15

52w Low $22.36

Volume 11,824

Avg Volume 28,161

Asset Class Equity

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.

HOLDINGS (Top 20)

Stock	Name	Weight	Shares	Market Value
LLY	Eli Lilly and Company	15.77%	9.00K	$8.31M
NVO	Novo Nordisk A/S	13.72%	183.83K	$7.23M
PFE	Pfizer Inc.	7.12%	138.42K	$3.75M
VKTX	Viking Therapeutics, Inc.	5.63%	83.57K	$2.97M
AMGN	Amgen Inc.	3.84%	5.76K	$2.02M
AZN	AstraZeneca PLC	3.81%	9.82K	$2.01M
REGN	Regeneron Pharmaceuticals, Inc.	3.18%	2.22K	$1.68M
GPCR	Structure Therapeutics Inc.	2.56%	25.38K	$1.35M
MBX	MBX Biosciences, Inc. Common Stock	2.13%	34.26K	$1.12M
GILD	Gilead Sciences, Inc.	1.88%	7.04K	$989.19K
RYTM	Rhythm Pharmaceuticals, Inc.	1.40%	8.46K	$738.65K
BHVN	Biohaven Ltd.	1.05%	53.09K	$554.30K
WVE	Wave Life Sciences Ltd.	0.46%	32.78K	$242.23K
CRBP	Corbus Pharmaceuticals Holdings, Inc.	0.42%	22.13K	$221.75K

SECTOR HOLDINGS

Healthcare

Healthcare

99.28%

Cash & Others

Cash & Others

0.67%

Financial Services

Financial Services

0.05%

ASSET ALLOCATION BY REGION

United States

45.52%

Denmark

18.90%

China

16.09%

Japan

4.78%

Switzerland

3.91%

United Kingdom

3.81%

South Korea

3.48%

Hong Kong

2.34%

Other

0.73%

Singapore

0.44%

SECTOR HOLDINGS

Healthcare

Healthcare

99.28%

Cash & Others

Cash & Others

0.67%

Financial Services

Financial Services

0.05%

ASSET ALLOCATION BY REGION

United States

45.52%

Denmark

18.90%

China

16.09%

Japan

4.78%

Switzerland

3.91%

United Kingdom

3.81%

South Korea

3.48%

Hong Kong

2.34%

Other

0.73%

Singapore

0.44%

Holdings (Top 20)

LLY

LLY

Eli Lilly and Company

Weight: 15.77% Shares: 9.00K Value: $8.31M

NVO

NVO

Novo Nordisk A/S

Weight: 13.72% Shares: 183.83K Value: $7.23M

PFE

PFE

Pfizer Inc.

Weight: 7.12% Shares: 138.42K Value: $3.75M

VKTX

VKTX

Viking Therapeutics, Inc.

Weight: 5.63% Shares: 83.57K Value: $2.97M

AMGN

AMGN

Amgen Inc.

Weight: 3.84% Shares: 5.76K Value: $2.02M

AZN

AZN

AstraZeneca PLC

Weight: 3.81% Shares: 9.82K Value: $2.01M

REGN

REGN

Regeneron Pharmaceuticals, Inc.

Weight: 3.18% Shares: 2.22K Value: $1.68M

GPCR

GPCR

Structure Therapeutics Inc.

Weight: 2.56% Shares: 25.38K Value: $1.35M

MBX

MBX

MBX Biosciences, Inc. Common Stock

Weight: 2.13% Shares: 34.26K Value: $1.12M

GILD

GILD

Gilead Sciences, Inc.

Weight: 1.88% Shares: 7.04K Value: $989.19K

RYTM

RYTM

Rhythm Pharmaceuticals, Inc.

Weight: 1.40% Shares: 8.46K Value: $738.65K

BHVN

BHVN

Biohaven Ltd.

Weight: 1.05% Shares: 53.09K Value: $554.30K

WVE

WVE

Wave Life Sciences Ltd.

Weight: 0.46% Shares: 32.78K Value: $242.23K

CRBP

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Weight: 0.42% Shares: 22.13K Value: $221.75K